MarketScreener Homepage > Equities > Nasdaq > Moderna, Inc. MRNA

Report

Real-time Estimate Cboe BZX - 01/26 02:23:41 pm
152.32	USD		+3.62%

01:46p

Johnson & Johnson's Profit Is Boosted by Pharmaceuticals Business -- 2nd Update

01:29p

44.3 MLN DOSES OF COVID-19 VACCINES DISTRIBUTED, 23.5 MLN ADMINISTERED : U.s. cdc

01:08p

PFIZER : Can COVID-19 vaccines be mixed and matched?

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

01/20/2021	01/21/2021	01/22/2021	01/25/2021	01/26/2021	Date
125.14(c)	132.98(c)	131.02(c)	147(c)	152.88	Last
8 001 568	20 880 838	10 067 191	26 970 870	13 645 635	Volume
+0.10%	+6.26%	-1.47%	+12.20%	+4.00%	Change

More quotes

Financials (USD)

Sales 2020	512 M - -
Net income 2020	-571 M - -
Net cash position 2020	2 597 M - -
P/E ratio 2020	-120x
Yield 2020	-

Sales 2021	9 689 M - -
Net income 2021	5 144 M - -
Net cash position 2021	9 212 M - -
P/E ratio 2021	12,0x
Yield 2021	-

Capitalization	58 169 M 58 169 M -
EV / Sales 2020	109x
EV / Sales 2021	5,05x
Nbr of Employees	1 100
Free-Float	90,0%

More Financials

Company

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows: - Collaboration revenue (79.8%); - Grant revenue (20.2%). At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and...

Sector

Biotechnology & Medical Research

Calendar

03/10

Earnings Release

More about the company

Notations Surperformance© of Moderna, Inc.

Trading Rating :

Investor Rating :

More Ratings

All news about MODERNA, INC.

01:46p	Johnson & Johnson's Profit Is Boosted by Pharmaceuticals Business -- 2nd Upda..	DJ
01:29p	44.3 MLN DOSES OF COVID-19 VACCINES : U.s. cdc	RE
01:08p	PFIZER : Can COVID-19 vaccines be mixed and matched?	AQ
12:48p	GAVI seeks political support for COVAX as rich nations strike fresh vaccine d..	RE
12:40p	J&J 4Q sales rise despite pandemic, but charges cut profits	AQ
12:10p	EU drugs agency says it is offering advice to makers of Russian vaccine	RE
12:02p	SOCIALIZING AFTER THE VACCINE : Experts say shot won't offer "free pass" right a..	AQ
11:50a	MODERNA : Canadians who have had COVID-19 should still get the vaccine, experts ..	AQ
11:26a	Canada's vaccine deliveries further threatened as Europe mulls export control..	AQ
09:03a	Johnson & Johnson's Profit Is Boosted by Pharmaceuticals Business --Update	DJ
08:32a	MODERNA : on Track to Deliver 100 Million Doses of COVID-19 Vaccine to US Govern..	MT
08:20a	Johnson & Johnson Profit Is Boosted by Pharmaceuticals Business	DJ
08:05a	MODERNA : Provides U.S. COVID-19 Vaccine Supply Update	BU
07:06a	MODERNA : WHO issues Moderna vaccine dosage recommendations	AQ
02:46a	Germany backs EU export restrictions on vaccine after supply cuts	RE

More news

News in other languages on MODERNA, INC.

01:47p	ROUNDUP 5 : Dritter Corona-Impfstoff in Sicht - aber wichtige offene Fragen
10:52a	WDH : Corona-Infektionszahlen in Israel weiter hoch - Impfdaten machen Mut
09:46a	SÖDER : Kein Export von Corona-Impfstoffen außerhalb von Europa
09:44a	VACCIN : Moderna en mesure de livrer 100 millions de doses aux USA au T1
09:43a	RKI : Zwei Prozent der Bevölkerung in Deutschland gegen Corona geimpft

More news

Analyst Recommendations on MODERNA, INC.

01/22	MODERNA : BofA Securities Adjusts Moderna PT to $140 From $130, Maintains Neutra..	MT
2020	MODERNA : Oppenheimer Adjusts Moderna PT to $178 From $157 on FDA Authorisation ..	MT
2020	MODERNA : Goldman Sachs Adjusts Moderna's Price Target to $171 From $139, Mainta..	MT

More recommendations

Stock Trading Strategies

	MODERNA, INC. - 2020
The beginning of the move

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Stocks lag, dollar advances on COVID-19 concerns